Please login to the form below

Not currently logged in

Insys gets bankruptcy court okay for Subsys sale

Opioid product was focus of racketeering charges

J&J puts pressure on rivals with new Erleada okay in prostate cancer

Johnson and Johnson logoFDA previously granted priority review in this indication

Takeda’s HAE drug Takhzyro backed by NICE

New treatment option for rare, hereditary disease

Roche wins FDA breakthrough for Gazyva in lupus nephritis

Roche - Basel, SwitzerlandDrug originally approved as a lymphoma treatment

FDA starts speedy review of Merck’s Ebola vaccine

First company to file for approval in the US

J&J's Tremfya filed for approval in US for psoriatic arthritis

Seeking share of increasingly competitive psoriasis market

Aimmune gets FDA panel backing for peanut allergy therapy

AimmuneStep closer to becoming first approved treatment

FDA fast-tracks AstraZeneca’s Farxiga in heart failure

AstraZeneca AZRaces to become first-in-class

AbbVie/Allergan's merger faces public opposition

AbbVie RedwoodAdvocacy groups and unions in the US express concerns

Brexit‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Latest regulatory appointments

Featured jobs

Subscribe to our email news alerts


Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...